4D Molecular Therapeutics
FDMT
$25.34
Share price
-1.17%
Change (1 day)
39.38%
Change (1 year)
Categories
4D Molecular Therapeutics (FDMT) - Total assets
Total assets on the balance sheet as of December 2023 : $0.33 B
According to 4D Molecular Therapeutics's latest financial reports the company's total assets are $0.33 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
4D Molecular Therapeutics - Total assets on balance sheet (from 2018 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.33 B | 29.81% |
| 2022-12-31 | $0.26 B | -25.92% |
| 2021-12-31 | $0.35 B | 22.6% |
| 2020-12-31 | $0.28 B | 395.12% |
| 2019-12-31 | $58.23 M | -39.95% |
| 2018-12-31 | $96.96 M | 254.94% |
| 2017-12-31 | $27.32 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.25 B | -25.86% | 🇺🇸 USA |